SBC Medical Group Holdings Incorporated (SBC)

Official site

INDUSTRIALS • CONSULTING SERVICES • NASDAQ

$5.32

-0.07 (-1.30%)

Market Cap: $530.69M

Last updated: Oct 16, 2026 at 5:00 PM ET

Earnings

Performance (10Y)

Beat Rate

50%(4/8)

Avg Surprise

-16.53%

Upcoming Estimates

Period ending Sep 30, 2026

EPS Consensus$0.12

Range$0.10 - $0.13

4 analysts

EPS RevisionsNo revisions (7d)

30d

EPS Estimate DriftChange to current

90d ago$0.12-2.1%

60d ago$0.12-2.1%

30d ago$0.120.0%

7d ago$0.120.0%

Current$0.12

Revenue Consensus

$49M

Range$44M - $52M

5 analysts

Period ending Dec 31, 2026

EPS Consensus$0.13

Range$0.09 - $0.15

4 analysts

Revenue Consensus

$55M

Range$47M - $62M

5 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$0.13	$0.09 - $0.15	-	-	4	-	-
Sep 30, 2026Sep 26EST	-	$0.12	$0.10 - $0.13	-	-	4	2 2 30d	-
Jun 30, 2026Jun 26 Reported Aug 13, 2026Reported Aug 13	$0.10	$0.12	$0.11 - $0.13	-16.67%	Miss	4	1 1 30d	+400.0%
Mar 31, 2026Mar 26 Reported May 14, 2026Reported May 14	$0.11	$0.10	$0.08 - $0.12	+10.00%	Beat	4	No revisions (30d)	-47.6%
Dec 31, 2025Dec 25 Reported Mar 27, 2026Reported Mar 27	$0.14	$0.11	$0.10 - $0.15	+27.27%	Beat	4	No revisions (30d)	+133.3%
Sep 30, 2025Sep 25 Reported Nov 14, 2025Reported Nov 14	$0.12	$0.11	$0.09 - $0.15	+9.09%	Beat	3	No revisions (30d)	+300.0%
Jun 30, 2025Jun 25 Reported Aug 13, 2025Reported Aug 13	$0.02	N/A	-	-85.71%	Miss	2	1 0 30d	-99.1%
Mar 31, 2025Mar 25 Reported May 15, 2025Reported May 15	$0.21	$0.11	-	+90.91%	Beat	-	-	+482.5%
Dec 31, 2024Dec 24 Reported Mar 28, 2025Reported Mar 28	$0.06	N/A	-	-68.42%	Miss	1	No revisions (30d)	+237.3%
Sep 30, 2024Sep 24 Reported Nov 13, 2024Reported Nov 13	$0.03	N/A	-	-98.73%	Miss	-	-	+257.9%
Jun 30, 2024Jun 24 Reported Aug 28, 2024Reported Aug 28	$2.33	N/A	-	N/A	Beat	-	-	+11156.0%
Mar 31, 2024Mar 24 Reported Jun 17, 2024Reported Jun 17	$-0.05	N/A	-	N/A	Beat	-	-	-234.9%
Dec 31, 2023Dec 23 Reported Dec 31, 2023Reported Dec 31	$-0.04	N/A	-	N/A	Beat	-	-	-209.2%
Sep 30, 2023Sep 23 Reported Sep 30, 2023Reported Sep 30	$-0.02	N/A	-	N/A	Beat	-	-	-2275.0%
Jun 30, 2023Jun 23 Reported Jun 30, 2023Reported Jun 30	$0.02	N/A	-	N/A	Beat	-	-	-
Mar 31, 2023Mar 23 Reported Mar 31, 2023Reported Mar 31	$0.04	N/A	-	N/A	Beat	-	-	-
Dec 31, 2022Dec 22 Reported Mar 9, 2023Reported Mar 9	$0.04	N/A	-	N/A	Beat	-	-	-
Sep 30, 2022Sep 22 Reported Nov 14, 2022Reported Nov 14	$-0.00	N/A	-	N/A	Beat	-	-	-
Jun 30, 2022Jun 22 Reported Sep 9, 2022Reported Sep 9	$0.00	$0.00	-	N/A	Beat	-	-	-

Key Metrics

Valuation
P/E Ratio	11.32	EV/EBITDA	5.06x
Price/FCF	8.83x	FCF Yield	11.32%
Profitability
Profit Margin	28.00%	Operating Margin	38.60%
ROE	18.90%	ROIC	16.66%
Financial Health
Debt/Equity	0.14x	Interest Coverage	217.09x
Current Ratio	3.31x	Quick Ratio	3.27x
Trading Statistics
Beta	0.55	Avg Volume	228.40K
52-Week High	$5.61	52-Week Low	$2.78

Technical Indicators Dashboard

Moving Averages

SMA 10$5.26

SMA 20$5.05

SMA 50$4.33

SMA 200$3.85

EMA 10$5.25

EMA 20$5.04

EMA 50$4.50

EMA 200$3.93

MACD

Line: 0.30Signal: 0.30Hist: -0.01

ADX

ADX: 56.1+DI: 30.6-DI: 8.4

Aroon & PSAR

Aroon Up100.0

Aroon DownN/A

PSAR$4.93

Bollinger Bands

Upper Band$5.60

Lower Band$4.51

%B Position2164%(Upper)

Band Width0.74

RSI (14-Day)

Neutral

66.9

Momentum Oscillators

Stoch %K81.6

Stoch %D83.3

Williams %R-30.5

ROC (10d)9.9%

Momentum0.48

CCI (20d)104.7

MFI (14d)69.8

Volatility Measures

ATR (14d)$0.25(4.7%)

StdDev (20d)0.27

Hist Vol48.6%(High)

Volume Flow

VWAP$5.39

OBV4.4M

AD Line2.8M

CMF (20d)0.004

Volume Metrics

Avg Vol (20d)229.3K

Vol Ratio0.9x

VWMA (20d)$5.04

Pivot Points

R3$5.69

R2$5.58

R1$5.49

Pivot Point$5.38

S1$5.29

S2$5.18

S3$5.09

Advanced Oscillators

TSI37.41

Ultimate Osc56.7

KST242.82

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$49.19M	$43.06M	$39.57M	$43.35M	$43.36M	$47.33M	$44.42M	$53.08M	$53.10M	$54.81M	$146.26M	$47.28M
Cost of Revenue	$13.21M	$12.71M	$10.64M	$12.74M	$13.35M	$9.60M	$10.55M	$9.85M	$13.68M	$15.29M	$42.40M	$13.78M
Gross Profit	$35.98M	$30.35M	$28.93M	$30.61M	$30.01M	$37.73M	$33.87M	$43.24M	$39.42M	$39.52M	$103.86M	$33.50M

Operating Expenses	$17.02M	$12.63M	$16.08M	$14.73M	$15.46M	$13.53M	$29.15M	$29.40M	$12.13M	$15.06M	$52.36M	$13.48M
R&D	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
SG&A	$17.02M	$12.63M	$16.08M	$14.73M	$15.46M	$13.53M	$13.88M	$16.60M	$12.13M	$15.06M	$0	$13.45M
Operating Income	$18.96M	$17.72M	$12.85M	$15.88M	$14.55M	$24.20M	$4.72M	$13.83M	$27.29M	$24.46M	$51.50M	$20.02M

Interest Income	$8,520	$121,369	$-284	$120,384	$22,882	$55,333	$-17,340	$7,950	$11,644	$17,689	$-2,024,849	$10,234
Interest Expense	$128,629	$114,806	$56,090	$48,635	$49,651	$6,207	$12,402	$5,466	$7,424	$3,008	$228,905	$3,978
Income Before Tax	$19.55M	$18.86M	$18.57M	$18.51M	$13.54M	$31.45M	$6.06M	$13.11M	$27.09M	$27.20M	$51.27M	$21.07M
Income Tax Expense	$7.82M	$7.53M	$4.29M	$5.67M	$11.10M	$9.96M	$-488,553	$10.27M	$8.53M	$8.45M	$21.58M	$13.01M

Net Income	$11.16M	$11.33M	$14.28M	$12.83M	$2.44M	$21.49M	$6.55M	$2.83M	$18.56M	$18.75M	$29.69M	$8.06M

EBITDA	$20.81M	$19.52M	$19.30M	$19.18M	$14.20M	$32.03M	$7.02M	$14.12M	$27.91M	$28.21M	$54.06M	$21.06M
EBIT	$19.67M	$18.85M	$18.62M	$18.44M	$13.57M	$31.40M	$6.09M	$13.11M	$27.08M	$27.19M	$51.50M	$21.06M

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about SBC

News

SBC Medical to Present at Cantor Fitzgerald Hong Kong’s Inaugural Asia Longevity Forum

SBC Medical Group Holdings Incorporated announced that Yuya Yoshida, Director, CFO, and COO, will speak at Cantor Fitzgerald Hong Kong's inaugural Asia Longevity Forum on October 26, 2026...

Yahoo Finance•Oct 12, 2026 9:40 AM ET10/12/26•Bullish

SBC Medical to present at Asia Longevity Forum and hold investor meetings in Hong Kong in October 2026

SBC Medical Group Holdings will present at Cantor Fitzgerald Hong Kong’s inaugural Asia Longevity Forum on October 26, 2026...

Pluang•Oct 12, 2026 9:10 AM ET10/12/26•Neutral

More than 40 companies will explore longevity investments. SBC Medical's CFO is set to speak.

SBC Medical Group Holdings (SBC) will present at Cantor Fitzgerald Hong Kong’s inaugural Asia Longevity Forum on October 26, 2026. Yuya Yoshida, Director, CFO, and COO, will speak at the event...

Stock Titan•Oct 12, 2026 9:10 AM ET10/12/26•Neutral

SBC Medical Group at Lytham Partners: ai, expansion drive growth

SBC Medical Group presented its growth strategy at the Lytham Partners Fall 2026 Investor Conference, emphasizing deeper penetration in Japanese aesthetic medicine, expansion into non-aesthetic healthcare...

Investing.com•Sep 30, 2026 3:25 AM ET9/30/26•Bullish

In October, SBC Medical plans online and New York meetings with investors.

SBC Medical Group Holdings (SBC) announced its participation in three investor conferences in October 2026, where it will hold presentations and one-on-one meetings with institutional investors. The events include...

Stock Titan•Sep 25, 2026 9:24 AM ET9/25/26•Neutral

SBC Valuation and Fair Value

P/E: 11.3x
Forward P/E: 9.3x
EV/EBITDA: 5.1x
P/FCF: 8.8x
PEG: 1.9x
P/B: 2.1x

See GNG's fair value

SBC Profitability: Margins, ROIC and FCF

Gross margin: 71.9%
Operating margin: 38.6%
Net margin: 28.0%
ROIC: 16.7%
ROE: 18.9%
FCF yield: 11.3%

SBC Competitors

Company	Ticker
Enovix Corp	ENVX
Kelly Services A Inc	KELYA
Enviri Corporation	NVRI
Hyster-Yale Materials Handling Inc	HY
Ennis Inc	EBF
Titan Machinery Inc	TITN
Limbach Holdings Inc	LMB
Pangaea Logistic	PANL

Sector: Industrials

SBC Analyst Ratings

Consensus: Buy
Analysts: 3
Strong Buy: 1
Buy: 2
Hold: 0
Sell: 0
Strong Sell: 0

SBC Bull Case vs Bear Case

Bull case

SBC earns a 16.7% return on invested capital.
SBC has a 28.0% net profit margin.
SBC grew quarterly revenue 13.4% year over year.

SBC Earnings: Beat Rate and Next Report

Beat rate: 4 of 8 quarters (50.0%)
Average surprise: -16.5%
EPS estimate (fiscal period ending Sep 30, 2026): $0.12
Estimate revisions (30 days, fiscal period ending Sep 30, 2026): 2 up, 2 down

Frequently Asked Questions About SBC

Does SBC pay dividends?

SBC Medical Group Holdings Incorporated (SBC) does not currently pay a regular dividend.

What is SBC's P/E ratio?

SBC Medical Group Holdings Incorporated has a price-to-earnings (P/E) ratio of 11.32.

What is SBC's market cap?

SBC Medical Group Holdings Incorporated (SBC) has a market capitalization of $530.69M with a current stock price of $5.32.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In